223 related articles for article (PubMed ID: 18755577)
1. Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.
Matsumoto RR; Shaikh J; Wilson LL; Vedam S; Coop A
Eur Neuropsychopharmacol; 2008 Dec; 18(12):871-81. PubMed ID: 18755577
[TBL] [Abstract][Full Text] [Related]
2. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
[TBL] [Abstract][Full Text] [Related]
3. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
[TBL] [Abstract][Full Text] [Related]
4. Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.
Matsumoto RR; Li SM; Katz JL; Fantegrossi WE; Coop A
Drug Alcohol Depend; 2011 Oct; 118(1):40-7. PubMed ID: 21420799
[TBL] [Abstract][Full Text] [Related]
5. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
Seminerio MJ; Kaushal N; Shaikh J; Huber JD; Coop A; Matsumoto RR
Pharmacol Biochem Behav; 2011 Mar; 98(1):12-20. PubMed ID: 21130800
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
Seminerio MJ; Hansen R; Kaushal N; Zhang HT; McCurdy CR; Matsumoto RR
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1033-44. PubMed ID: 22932447
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
[TBL] [Abstract][Full Text] [Related]
8. AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.
Kaushal N; Elliott M; Robson MJ; Iyer AK; Rojanasakul Y; Coop A; Matsumoto RR
Mol Pharmacol; 2012 Mar; 81(3):299-308. PubMed ID: 22101517
[TBL] [Abstract][Full Text] [Related]
9. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.
Robson MJ; Turner RC; Naser ZJ; McCurdy CR; Huber JD; Matsumoto RR
Exp Neurol; 2013 Sep; 247():134-42. PubMed ID: 23631864
[TBL] [Abstract][Full Text] [Related]
10. Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.
Brammer MK; Gilmore DL; Matsumoto RR
Eur J Pharmacol; 2006 Dec; 553(1-3):141-5. PubMed ID: 17070798
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
[TBL] [Abstract][Full Text] [Related]
12. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
13. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
Itzhak Y; Martin JL; Black MD; Ali SF
Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
[TBL] [Abstract][Full Text] [Related]
14. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
Hiranita T; Soto PL; Kohut SJ; Kopajtic T; Cao J; Newman AH; Tanda G; Katz JL
J Pharmacol Exp Ther; 2011 Nov; 339(2):662-77. PubMed ID: 21859929
[TBL] [Abstract][Full Text] [Related]
15. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
Terleckyj I; Sonsalla PK
J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
[TBL] [Abstract][Full Text] [Related]
17. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.
Zolkowska D; Jain R; Rothman RB; Partilla JS; Roth BL; Setola V; Prisinzano TE; Baumann MH
J Pharmacol Exp Ther; 2009 May; 329(2):738-46. PubMed ID: 19197004
[TBL] [Abstract][Full Text] [Related]
19. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
20. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
